Psilocybin can be produced de novo in yeast. The findings could help with the development of drugs that utilize the psychedelic compound to treat depression and other mental health disorders.
Computational simulations reveal the integration of both neuronal and neurotransmitter systems at a whole-brain level is vital to fully understand the effects of psilocybin on brain activity.
A single dose of the psychedelic psilocybin reduces depression, anxiety, and feelings of hopelessness in cancer patients for 12 months after the drug is administered.
Numerous recent studies claim psychedelics, such as psilocybin, can help treat a range of mental health problems from depression to PTSD. Researchers investigate how psychedelics can help us become more "nature-connected" and increase a sense of environmental responsibility.
Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness, after the effect of the drug has worn off.
Backing up previous research, a new study reveals psychedelics can have beneficial effects for treating PTSD when combined with traditional trauma-focused psychotherapy. Findings suggest MDMA assisted therapy is significantly more effective at treating patients with persistent PTSD than psychotherapy alone.
Study discussed the benefits of using psychedelics as an antidepressant option for those with depression.
Mindful meditation enhances the positive effects of a single dose of psilocybin by increasing empathy and reducing egocentricity.
Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.
Those who microdose psychedelics report improved mood, greater focus, and increased creativity. A new study looks at the positive outcomes of microdosing and suggests others look at potential long-term negative consequences of using psychedelics.
While many people report microdosing is beneficial to their mental wellbeing, researchers say more research needs to be conducted to evaluate the psychological and health implications of taking low-dose psychedelics.
Microdosing, a growing trend where people take small doses for psychedelic drugs, is associated with improved mood, focus, and creativity. For some, microdosing may provide a possible alternative to SSRI antidepressants. However, researchers warn of some potential problems with microdosing, including negative side effects, psychological stigma, and exposure to elicit, black market products.
